Search Results

You searched for : Keytruda  

	Top Causes of Fatigue Explained Understanding extreme fatigue causes involves examining sleep quality, inflammation, stress, nutrition, and chronic health conditions together rather than separately. Recognizing what causes extreme fatigue early ... May 12
	Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients Latest news updates... Oct 26
	Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106 Latest Pharma Update... Aug 23
	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ... Jul 12
	M2GEN announces new collaboration with Merck to advance Cancer therapies Another pharma collaboration for the advancement of cancer therapies ... Mar 22
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA ... Dec 18
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options... Dec 17
	KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival ... Dec 16
	Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability ... Dec 11
	I-Mab accelerates clinical development of anti-CD47 monoclonal antibody lemzoparlimab in the US and China I-Mab's global collaboration with AbbVie will facilitate global development of lemzoparlimab... Dec 05
	KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
	BriaCell announces the overall breast cancer survival (OS) data of its lead product candidate, Bria-IMT™ Median OS of 13.3 months has been observed in the Phase I/IIa study for patients treated with Bria-IMT™ in combination with immune ... Oct 21
	Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy NKMax America has developed a proprietary NK cell expansion and activation technology platform which allows it to produce unprecedented commercial amounts of autologous and allogeneic ... Oct 20
	Merck received US FDA approval for Keytruda FDA approves expanded indication for Merck’s KEYTRUDA (pembrolizumab) in adult patients with relapsed or refractory classical hodgkin lymphoma (cHL) ... Oct 16
	FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL) ... Oct 15
	PharmAbcine entered into a strategic partnership with Samsung Biologic PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibodies to treat cancer and neovascular disease... Sep 22
	Merck’s KEYTRUDA Receives Two New Approvals in Japan Keytruda would be soon launched in Japan for the treatment of cancerous tumors... Aug 27
	PharmAbcine signs manufacturing agreement with Binex PharmAbcine signs long-term contract manufacturing organization agreement for Olinvacimab with Binex ... Jun 27
	Scientists Create Antibody That Defeats Coronavirus in Lab The experimental antibody has neutralized the virus in cell cultures. While that's early in the drug development process, the antibody may help prevent or ... May 05
	US drug market will see Novartis, Merck and Allergan to hike their prices on entire product portfolio Novartis,Allergan and Merck joins the list after Pfizer,increases drug prices in US... Jan 07
20 Matching result(s) found!

Trending Now
	AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
	AI and Patient Consent in India: Who Is Responsible?October 06, 2026
	Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
	Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
	Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
	Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
	Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
	Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
	Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
	Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
	Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
	The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
	Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
	Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
	Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
	CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
	Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
	Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
	Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
	Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026